AxoGen Investor Relations Material
Latest events
Q1 2024
AxoGen
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies
Latest reports from AxoGen Inc
Access all reports
AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for peripheral nerve injury. It provides Avance Nerve Graft, an off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgical site; AxoGuard Nerve Connector that is a porcine submucosa extracellular matrix (ECM) coaptation aid for tensionless repair of severed nerves; and AxoGuard Nerve Protector that is a porcine submucosa ECM product used to wrap and protect damaged peripheral nerves and reinforce the nerve reconstruction while preventing soft tissue attachments. The company also offers Avive Soft Tissue Membrane that is a processed human umbilical cord membrane used as a resorbable barrier to separate tissues in repair or reconstruction procedures; and AcroVal Neurosensory & Motor Testing System.
Key slides for AxoGen Inc
Q3 2023
AxoGen Inc
Q3 2023
AxoGen Inc
Latest articles
The Birkin Bag: The Story Behind the World's Most Desired Handbag
How the Birkin bag became the world's most sought-after handbag where even the wealthy must earn the right to own one.
12 Jul 2024
The 10 Largest Semiconductor Companies in the World
Discover the top 10 semiconductor companies by market cap, exploring their innovations and business models shaping the tech landscape.
10 Jul 2024
The Rise of Nubank: Changing Latin American Finance
Discover how Nubank revolutionized Latin American banking with innovation, backed by top investors like Berkshire Hathaway.
9 Jul 2024
Ticker symbol
AXGN
Country
🇺🇸 United States